Membrane Protein Complex Purification with pH-Switched Polymer Elution
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Conventional surfactant-based methods for eluting membrane proteins from biological membranes often decompose protein complexes, making it difficult to maintain their complex form and reveal protein relationships.
Innovation Solution
Using synthetic polymers, particularly amphiphilic polymers, to elute membrane protein complexes while maintaining their complex form, followed by a method involving a protein binding step at pH 6.0 or higher, a protein eluting step at pH 6.0 or higher, and a synthetic polymer removing step at pH 7.0 or lower.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If surfactants are used to elute membrane proteins, then individual proteins can be separated and eluted, but the structures of membrane protein complexes are decomposed
Solution Approach 1:
The patent changes the chemical parameters of the elution agent from conventional surfactants to synthetic polymers with specific molecular weight ranges (1,000-100,000). This parameter change allows the polymer to interact with membrane proteins differently, maintaining complex structures while enabling separation, thus resolving the contradiction between separation efficiency and complex integrity
Solution Approach 2:
The patent uses synthetic polymers that can form composite structures with membrane proteins and lipids. These polymer-protein-lipid complexes maintain the native protein interactions while allowing for subsequent separation, addressing both the need for complex preservation and eventual separation
2Stability of the object's composition
If synthetic polymers are used to maintain complex form, then membrane protein complexes can be eluted intact, but conventional acidic elution methods fail to elute proteins
Solution Approach 1:
The patent inverts the conventional elution approach by using alkaline conditions (pH 6.0 or higher) instead of acidic conditions. This inversion is necessary because the synthetic polymer-protein complex requires basic conditions for effective elution, reversing the traditional paradigm while maintaining complex integrity
Solution Approach 2:
The synthetic polymer acts as an intermediary that facilitates both complex stabilization during elution and subsequent release under alkaline conditions. The polymer mediates between maintaining structural integrity and enabling efficient protein release, solving the contradiction between stability and ease of operation
3Ease of operation
If alkaline conditions are used for protein elution, then proteins can be eluted from antibodies, but efficiency of removing synthetic polymer decreases
Solution Approach 1:
The patent segments the purification process into distinct stages: first eluting proteins under alkaline conditions to maintain complex integrity, then removing the synthetic polymer separately under acidic conditions. This segmentation allows each step to be optimized independently, resolving the contradiction between protein elution efficiency and polymer removal efficiency
Solution Approach 2:
The patent employs periodic alternation between alkaline and acidic conditions in different processing stages. Alkaline conditions are used when protein elution is needed, while acidic conditions are used when polymer removal is the priority. This periodic switching of conditions optimizes both functions without compromise
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The method enables the purification of membrane protein complexes in their intact form, providing information on protein interactions and allowing for the separation of individual proteins from the complex.
Implementation Method 1
when synthetic polymers, especially amphiphilic polymers, are used instead of surfactants, it has been found that membrane protein complexes can be eluted while maintaining their complex form
Implementation Method 2
a protein binding step of binding to an antibody a membrane protein complex eluted from a membrane using a synthetic polymer
Implementation Method 3
a protein eluting step of eluting the membrane protein complex bound to the antibody in the protein binding step at a pH of 6.0 or higher
Implementation Method 4
a synthetic polymer removing step of subjecting the membrane protein complex eluted in the protein eluting step to solvent extraction at a pH of 7.0 or lower to remove the synthetic polymer
Data Source
AI summary
The present disclosure aims to provide a method which, even when a protein complex is formed, can purify a protein derived from such a membrane protein complex by eluting the membrane protein complex maintaining its complex form. The present disclosure relates to a method for purifying a protein derived from a membrane protein complex, which includes: a protein binding step of binding to an antibody a membrane protein complex eluted from a membrane using a synthetic polymer; a protein eluting step of eluting the membrane protein complex bound to the antibody in the protein binding step at a pH of 6.0 or higher; and a synthetic polymer removing step of subjecting the membrane protein complex eluted in the protein eluting step to solvent extraction at a pH of 7.0 or lower to remove the synthetic polymer.